February 22, 2021 — The U.S. Food and Drug Administration (FDA) recently cleared the Cook Medical Zilver Vena Venous ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...
February 16, 2021 – SpectraWave Inc. announced a $13.2 million series A-2 financing to support completion of product ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
February 9, 2021 — InspireMD Inc., developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke ...
February 9, 2021 — EndoWays, developer of a disposable robotic system for the cath lab, announced the completion of an ...
February 8, 2021 — Teleflex Inc. said it recently completed its acquisition of Z-Medica LLC, an industry-leading ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
Cindy Grines, M.D., MSCAI, FACC, president of the Society for Cardiovascular Angiography and Interventions (SCAI), and ...
February 4, 2021 — Transcatheter aortic valve replacement (TAVR) has historically only been used with caution in the ...
February 3, 2021 — Modern Vascular is a medical group that has 13 outpatient cath lab clinics to treat peripheral artery ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation ...
January 26, 2021 — Pedra Technology, a privately held company, announced today that the U.S. Food and Drug ...
January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
With increasing complexity of interventional structural heart disease and congenital heart disease interventions, 3-D ...
January 20, 2021 — The U.S. Centers for Medicare and Medicaid Services (CMS) revised its National Coverage Determination ...
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve ...
February 22, 2021